Pasireotide does not prevent postoperative pancreatic fistula: a prospective study.

Author: DamatoLauren, DannAmanda M, DonahueTimothy R, ElliottIrmina A, GhukasyanRazmik, GirgisMark D, HinesO J, KingJonathan C, ReberHoward A

Paper Details 
Original Abstract of the Article :
BACKGROUND: Pancreatic fistula is a major cause of morbidity after pancreas surgery. In 2014, a single-center, randomized-controlled trial found pasireotide decreased pancreatic fistula rates. However, this finding has not been validated, nor has pasireotide been widely adopted. METHODS: A single-a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.hpb.2017.10.018

データ提供:米国国立医学図書館(NLM)

Pasireotide for Postoperative Pancreatic Fistula: A Mirage in the Desert

Postoperative pancreatic fistula, a serious complication after pancreas surgery, poses a significant challenge for patients and surgeons alike. This prospective study, published in [journal name], investigates the effectiveness of pasireotide, a somatostatin analog, in preventing pancreatic fistula. The researchers, like explorers seeking a reliable oasis in a harsh desert, hoped to find a solution to this debilitating complication.

Pasireotide's Limited Effectiveness: A Deceptive Oasis

The study, like a weathered map revealing a different reality, found that pasireotide did not significantly reduce the rate of pancreatic fistula. The findings, like a dry riverbed leading to a disappointing end, highlight the need for alternative approaches to prevent this complication. This research underscores the complexity of treating pancreatic fistula and the importance of exploring new strategies to improve patient outcomes.

Navigating Pancreatic Fistula: A Desert of Uncertainty

The study's findings, like a compass pointing towards a new direction, emphasize the need for continued research to identify effective methods for preventing and treating pancreatic fistula. The journey towards improving patient care after pancreas surgery requires a persistent commitment to finding solutions that address this challenging complication.

Dr.Camel's Conclusion

This study, like a desert traveler encountering a mirage, reminds us that the search for solutions in medicine can sometimes lead to unexpected outcomes. While pasireotide did not prove to be a reliable preventative measure for pancreatic fistula, this research underscores the importance of persistent exploration and innovative approaches to address this complex complication. The quest for effective treatments continues, demanding a commitment to finding new oases of hope for patients facing this challenging condition.

Date :
  1. Date Completed 2019-06-07
  2. Date Revised 2019-06-07
Further Info :

Pubmed ID

29398424

DOI: Digital Object Identifier

10.1016/j.hpb.2017.10.018

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.